OTCMKTS:WILYY Demant A/S (WILYY) Stock Price, News & Analysis $18.99 0.00 (0.00%) As of 08/15/2025 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock About Demant A/S Stock (OTCMKTS:WILYY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Demant A/S alerts:Sign Up Key Stats Today's Range$18.99▼$18.9950-Day Range$18.99▼$21.9352-Week Range$15.03▼$21.93Volume4,211 shsAverage Volume402 shsMarket Capitalization$8.12 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingBuy Company Overview Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets and solutions for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark. Read More Receive WILYY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Demant A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address WILYY Stock News HeadlinesBarclays Sticks to Its Hold Rating for Demant (WILLF)August 15 at 10:33 AM | theglobeandmail.comDemant price target raised to DKK 291 from DKK 274 at JPMorganAugust 14, 2025 | msn.comWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.August 18 at 2:00 AM | Priority Gold (Ad)Demant AS (WILLF) Q2 2025 Earnings Call Highlights: Strong Cash Flow and Strategic Acquisitions ...August 14, 2025 | finance.yahoo.comDemant A/S Reports Modest Growth Amid ChallengesAugust 14, 2025 | msn.comDemant A/S Reports Modest Growth Amid Market ChallengesAugust 14, 2025 | msn.comDemant A/S (WILLF) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | seekingalpha.comDemant shares down after Q2 miss, guidance cut on softer hearing aid demandAugust 13, 2025 | ca.investing.comSee More Headlines WILYY Stock Analysis - Frequently Asked Questions How have WILYY shares performed this year? Demant A/S's stock was trading at $18.66 at the beginning of 2025. Since then, WILYY shares have increased by 1.8% and is now trading at $18.9926. How do I buy shares of Demant A/S? Shares of WILYY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today8/18/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED PRODUCTS Sub-IndustryN/A Current SymbolOTCMKTS:WILYY Previous SymbolNASDAQ:WILYY CIKN/A Webwww.demant.com Phone(453) 917-7300Fax45-3927-8900Employees22,639Year Founded1904Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio1.29 Current Ratio1.63 Quick Ratio1.22 Sales & Book Value Annual Sales$3.25 billion Price / Sales2.50 Cash Flow$0.95 per share Price / Cash Flow20.02 Book Value$3.16 per share Price / Book6.01Miscellaneous Outstanding Shares427,590,000Free FloatN/AMarket Cap$8.12 billion OptionableNot Optionable Beta0.94 Social Links 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (OTCMKTS:WILYY) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Demant A/S Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Demant A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.